Clinical Trials Browser

Phase 2 × N-Methyl-3,4-methylenedioxyamphetamine × Clear all

NCT05584826 2025-04-23

MDMA-assisted Therapy for Adjustment Disorder (AD) in Dyads of Patients With Cancer and a Concerned Significant Other

Phase 2 Recruiting

Adjustment Disorders, Neoplasms

NCT00252174 2017-11-14

MDMA-assisted Therapy in People With Anxiety Related to Advanced Stage Cancer

Phase 2 Terminated

2 enrolled 6 charts

Anxiety Disorders, Neoplasms